Impaired 1,25 dihydroxyvitamin D3 action and hypophosphatemia underlie the altered lacuno-canalicular remodeling observed in the Hyp mouse model of XLH.
Osteocytes remodel the perilacunar matrix and canaliculi. X-linked hypophosphatemia (XLH) is characterized by elevated serum levels of fibroblast growth factor 23 (FGF23), leading to decreased 1,25 dihydroxyvitamin D3 (1,25D) production and hypophosphatemia. Bones from mice with XLH (Hyp) have enlar...
Guardado en:
Autores principales: | Ye Yuan, Supriya Jagga, Janaina S Martins, Rakshya Rana, Paola Divieti Pajevic, Eva S Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bf985ffd452b4e6381159e0ec86ab2a8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
1,25-Dihydroxyvitamin D Inhibits Osteoarthritis by Modulating Interaction Between Vitamin D Receptor and NLRP3 in Macrophages
por: Duan A, et al.
Publicado: (2021) -
1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis.
por: Jae-Hoon Chang, et al.
Publicado: (2010) -
Life-threatening hypophosphatemia following intravenous iron infusion
por: George Vasquez-Rios, et al.
Publicado: (2021) -
NADPH-cytochrome P450 reductase is regulated by all-trans retinoic acid and by 1,25-dihydroxyvitamin D3 in human acute myeloid leukemia cells.
por: Elżbieta Gocek, et al.
Publicado: (2014) -
A modified technique of retrograde intubation dacryocystorhinostomy for proximal canalicular obstruction
por: Nikolaos Trakos, et al.
Publicado: (2009)